首页> 外文期刊>Adolescent Health, Medicine and Therapeutics >A comparative study of propranolol versus silver nitrate cautery in the treatment of recurrent primary epistaxis in children
【24h】

A comparative study of propranolol versus silver nitrate cautery in the treatment of recurrent primary epistaxis in children

机译:普萘洛尔与硝酸银烧灼治疗儿童复发性原发性鼻出血的比较研究

获取原文
       

摘要

Background: Epistaxis is a common medical problem in pediatric population. Although in most cases it is mild and self-limiting, a proportion of childhood epistaxis is massive, recurrent, or resistant to conventional management. Objective: To compare effectiveness of propranolol as a treatment option for childhood epistaxis versus conventional silver nitrate cautery. Study design and methodology: This is a prospective interventional comparative study that was carried out during a period of 1 year (January 1, 2013 to December 31, 2013) at Qena University Hospital and Assiut University Children's Hospital. One hundred children aged 6–12 years who presented with epistaxis to Qena University Hospital and Assiut University Children's Hospital during the study period and fulfilling the inclusion criteria were included in the study. They were randomly assigned into one of two interventional groups, where 50 children were treated with oral propranolol (propranolol treatment group) and another 50 children were treated with conventional silver nitrate cautery (cauterization treatment group) for their epistaxis. Propranolol was given at a dose of 1.5–2 mg/kg/day (divided into three doses). Patients were followed for 6 months after their discharge for recurrence of epistaxis. Results: Both groups of patients showed minimal recurrent epistaxis with rates of 14% for propranolol treated group and 12% for cauterization group, with no statistically significant difference between both groups. Local pain was found to be more in patients treated with silver nitrate cauterization. Conclusion: Treatment of primary epistaxis with propranolol or silver nitrate cautery showed equal rates of recurrence, and local nasal pain was slightly more among silver nitrate cauterization treated group. Propranolol could be a favorable treatment option for patients with primary epistaxis. Further studies that include multiple centers and larger number of patients are recommended for more clarification of the effectiveness of such treatment option.
机译:背景:鼻出血是儿童人群中常见的医学问题。尽管在大多数情况下它是温和的并且是自我限制的,但儿童期的鼻axis病比例很大,反复发作或对常规治疗有抵抗力。目的:比较普萘洛尔作为儿童鼻出血治疗方法与常规硝酸银烧灼治疗方法的有效性。研究设计和方法:这是一项前瞻性干预比较研究,在Qena大学医院和Assiut大学儿童医院的1年(2013年1月1日至2013年12月31日)内进行。在研究期间,有100名6-12岁的儿童在研究期间出现鼻出血,这些儿童在Qena大学医院和Assiut大学儿童医院就诊并符合纳入标准。他们被随机分为两个干预组中的一个,其中50名儿童接受口服普萘洛尔治疗(普萘洛尔治疗组),另外50名儿童接受常规硝酸银烧灼治疗(电灼治疗组)以改善鼻epi。普萘洛尔的剂量为1.5–2 mg / kg /天(分为三剂)。出院后随访患者6个月,以恢复鼻epi。结果:两组患者均表现出最低程度的复发性鼻炎,普萘洛尔治疗组的复发率为14%,烧灼组的率为12%,两组之间无统计学差异。发现用硝酸银烧灼治疗的患者局部疼痛更多。结论:普萘洛尔或硝酸银烧灼治疗原发性鼻st复发率相同,硝酸银烧灼治疗组局部鼻痛略多。普萘洛尔对于原发性鼻axis患者可能是一种有利的治疗选择。建议进一步研究包括多个中心和更多患者,以进一步阐明这种治疗方案的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号